Neurodivergent Australians have the skills many employers need. Here’s how one organisation, with support from the William Buckland Foundation, managed by Equity Trustees, is creating pathways to employment by rethinking recruitment and workplace practices.

From an Australian laboratory to potential clinical trials, Dr Jiang-Hui (Sloan) Wang’s research is exploring new ways to deliver gene therapy to the eye.

The August reporting season in Australia was better than feared but not as strong as the headline numbers suggest. Companies broadly exceeded downgraded expectations, driven primarily by margin resilience, cost control and stronger resource earnings, rather than robust revenue growth.